FTUS
MTACU

Flow Traders U.S.’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Flow Traders U.S.’s Portfolio MTACU Stock Details MTACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-148,977
Closed -$1.51M – 1173
2021
Q1 		$1.5M Buy
+148,977
New +$1.58M 0.08% 241

Other funds holding MTACU

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HP
Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Flow Traders U.S.'s MTACU Position: Q2 2021 in Review

Flow Traders U.S. sold out of MedTech Acquisition Corporation Unit (MTACU) in Q2 2021, closing a stake of 148,977 shares — an estimated $1.51M sold.

Flow Traders U.S. first reported a position in MTACU in Q1 2021 and held it in 1 quarter. The position peaked at $1.5M in Q1 2021. 30 funds tracked by Wall St. Rank hold MTACU as of Q2 2021.

  • Flow Traders U.S. reported no remaining MedTech Acquisition Corporation Unit position as of Q2 2021 after selling out during the quarter.
  • Flow Traders U.S. sold 148,977 MedTech Acquisition Corporation Unit shares in Q2 2021, an estimated $1.51M.
  • Flow Traders U.S. first reported a position in MedTech Acquisition Corporation Unit in Q1 2021 and held it in 1 quarter.
  • Flow Traders U.S.'s MedTech Acquisition Corporation Unit position peaked at $1.5M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q2 2021.

Based on Flow Traders U.S.'s 13F filing for Q2 2021, filed 16 Aug 2021.